| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 726502 | 1191374004 | ESPEROCT 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 2000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 2000 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374004/1191374004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374004/1191374004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-13 | View Edit Delete | ||||||||||||
| 726503 | 1191374005 | ESPEROCT 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ESPEROCT 3000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 3000 UI | 80 | 1 | 34 | 1 vial, 1 jeringa precargada, 1 émbolo, 1 adaptador del vial | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191374005/1191374005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191374005/1191374005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2019-10-07 | 1 | 1 | 1 | 2019-10-08 | 2019-10-07 | 1 | 2019-12-12 | View Edit Delete | ||||||||||||
| 726298 | 1191376001 | LIBTAYO 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | LIBTAYO 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191376001/1191376001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191376001/1191376001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 36484 | REGENERON SPAIN S.L.U. | 2019-07-29 | 1 | 1 | 1 | 2019-07-30 | 2019-07-29 | 1 | 2022-04-04 | View Edit Delete | ||||||||||||
| 726297 | 1191377001 | TALZENNA 0,25 MG CAPSULAS DURAS | TALZENNA 0,25 MG CAPSULAS DURAS, 30 cápsulas | 0,25 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191377001/1191377001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191377001/1191377001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2019-07-24 | 1 | 1 | 1 | 2019-07-25 | 2019-07-24 | 1 | 2024-12-13 | View Edit Delete | ||||||||||||
| 726617 | 1191379002 | POSACONAZOL ACCORD 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG | POSACONAZOL ACCORD 100 MG COMPRIMIDOS GASTRORRESISTENTES EFG, 24 comprimidos | 100 mg | 5 | 24 | 10 | 24 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191379002/1191379002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191379002/1191379002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2019-10-17 | 1 | 1 | 1 | 2019-10-18 | 2019-10-17 | 1 | 2019-12-14 | View Edit Delete | ||||||||||||
| 726616 | 1191380001 | POSACONAZOL AHCL 40 MG/ML SUSPENSION ORAL EFG | POSACONAZOL AHCL 40 MG/ML SUSPENSION ORAL EFG, 1 frasco de 105 ml | 40 mg/ml | 6 | 105 | 26 | 1 frasco de 105 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191380001/1191380001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191380001/1191380001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2019-09-24 | 1 | 1 | 1 | 2019-09-25 | 2019-09-24 | 1 | 2019-12-13 | View Edit Delete | ||||||||||||
| 763069 | 1191384003 | GIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | GIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales de 1 ml | 2,5 mg/ml inyectable 1 ml | 45 | 10 | 34 | 10 viales de 1 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191384003/1191384003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191384003/1191384003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 67729 | VIATRIS PHARMACEUTICALS S.L.U. | 2023-07-31 | 1 | 1 | 1 | 2023-08-01 | 2023-07-31 | 1 | 2025-01-23 | View Edit Delete | ||||||||||||
| 726876 | 1191385001 | VITRAKVI 25 MG CAPSULAS DURAS | VITRAKVI 25 MG CAPSULAS DURAS, 56 cápsulas | 25 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191385001/1191385001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191385001/1191385001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2019-11-21 | 1 | 1 | 1 | 2019-11-22 | 2019-11-21 | 1 | 2024-03-21 | View Edit Delete | ||||||||||||
| 726877 | 1191385002 | VITRAKVI 100 MG CAPSULAS DURAS | VITRAKVI 100 MG CAPSULAS DURAS, 56 cápsulas | 100 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191385002/1191385002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191385002/1191385002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2019-11-21 | 1 | 1 | 1 | 2019-11-22 | 2019-11-21 | 1 | 2023-10-10 | View Edit Delete | ||||||||||||
| 732025 | 1191385004 | VITRAKVI 20 MG/ML SOLUCION ORAL, 2 frascos de 50 ml | VITRAKVI 20 MG/ML SOLUCION ORAL, 2 frascos de 50 ml | 20 mg/ml | 6 | 100 | 26 | 2 frascos de 50 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191385004/1191385004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191385004/1191385004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2019-11-21 | 1 | 1 | 1 | 2019-11-22 | 2021-10-14 | 1 | 2023-10-18 | View Edit Delete | ||||||||||||
| 727843 | 1191388001 | POLIVY 140 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POLIVY 140 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 140 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191388001/1191388001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191388001/1191388001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29096 | ROCHE FARMA S.A. | 2020-02-18 | 1 | 1 | 1 | 2020-02-19 | 2020-02-18 | 1 | 2021-08-27 | View Edit Delete | ||||||||||||
| 729638 | 1191388002 | POLIVY 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POLIVY 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 30 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191388002/1191388002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191388002/1191388002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29096 | ROCHE FARMA S.A. | 2020-10-28 | 1 | 1 | 1 | 2020-10-29 | 2020-10-28 | 1 | 2021-08-27 | View Edit Delete | ||||||||||||
| 727061 | 1191389001 | EPIDYOLEX 100 MG/ML SOLUCION ORAL | EPIDYOLEX 100 MG/ML SOLUCION ORAL, 1 frasco de 100 ml | 100 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191389001/1191389001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191389001/1191389001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 35481 | JAZZ PHARMACEUTICALS IBERIA S.L. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2021-08-03 | View Edit Delete | ||||||||||||
| 732440 | 1191390002 | INBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURAS | INBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURAS, 92 capsulas y 1 inhalador | 33 mg/dosis | 7 | 92 | 43 | 92 capsulas y 1 inhalador | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191390002/1191390002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191390002/1191390002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39463 | ESTEVE PHARMACEUTICALS S.A. | 2021-12-21 | 1 | 1 | 1 | 2021-12-22 | 2021-12-21 | 1 | 2022-12-05 | View Edit Delete | ||||||||||||
| 731056 | 1191393001 | QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales | 300 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191393001/1191393001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191393001/1191393001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32477 | LABORATORIOS MENARINI S.A. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-11-29 | View Edit Delete | ||||||||||||
| 731057 | 1191393002 | QUOFENIX 450 mg COMPRIMIDOS | QUOFENIX 450 mg COMPRIMIDOS, 10 comprimidos | 450 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191393002/1191393002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191393002/1191393002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32477 | LABORATORIOS MENARINI S.A. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-11-29 | View Edit Delete | ||||||||||||
| 728670 | 1191394002 | TIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG | TIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG, 10 viales | 50 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191394002/1191394002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191394002/1191394002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2020-06-08 | 1 | 1 | 1 | 2020-06-09 | 2020-06-08 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 730482 | 1191397001 | BORTEZOMIB FRESENIUS KABI 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG | BORTEZOMIB FRESENIUS KABI 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 vial | 3,5 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191397001/1191397001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191397001/1191397001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2021-02-26 | 1 | 1 | 1 | 2021-02-27 | 2021-02-26 | 1 | 2022-01-26 | View Edit Delete | ||||||||||||
| 727422 | 1191398003 | TRIOXIDO DE ARSENICO ACCORD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TRIOXIDO DE ARSENICO ACCORD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 10 viales de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 10 | 34 | 10 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191398003/1191398003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191398003/1191398003_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2019-12-26 | 1 | 1 | 1 | 2019-12-27 | 2019-12-26 | 1 | 2020-04-22 | View Edit Delete | ||||||||||||
| 727277 | 1191399001 | XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 84 comprimidos | 40 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191399001/1191399001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191399001/1191399001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2023-05-12 | View Edit Delete |
Page 108 of 1035, showing 20 records out of 20697 total, starting on record 2141, ending on 2160